Viral Hepatitis

Infographic Pharmacist-initiated naloxone and syringe furnishing in California January 18, 2024 Infographic highlighting some of the results from the 2022 California Pharmacist Survey. Pharmacists were asked about their furnishing of naloxone and syringe without an outside provider’s prescription. Includes some policy implications.   — Image by Freepik Download Authors Northern California HIV/AIDS Policy Research Center

Infographic Modeling the Impact of Supervised Consumption Sites on HIV and HCV Transmission among People who Inject Drugs in Three California Counties October 11, 2023 Supervised consumption sites (SCS) are harm reduction programs in which people who inject drugs (PWID) bring their previously obtained drugs to consume in a supervised setting. We modeled the potential […]

Infographic 2021 COVID-19 Organizational Health Survey June 13, 2022 In the fall of 2021, the California HIV/AIDS Policy Research Centers conducted an online survey to document the direct impact of COVID-19 on healthcare and social services providers working to address HIV, viral hepatitis and sexually transmitted infections (STIs). Survey respondents included 30 organizations that submitted […]

Meeting Proceedings Policy and Research Priorities to End the Epidemics of HIV, Viral Hepatitis, STIs, and Overdose: a California HIV/AIDS Policy Research Centers and End the Epidemics community convening December 29, 2021 On November 10, 2021, the California HIV/AIDS Policy Research Centers (CHPRC) and the statewide End the Epidemics coalition (ETE) convened a community meeting […]

Meeting Proceedings SCHPRC San Diego Launch Meeting July 1, 2021 On June 4, 2021, the Southern California HIV/AIDS Policy Research Center (SCHPRC) hosted a launch meeting for San Diego County, organized on the heels of a regional listening session led by the NIH Office of AIDS Research. During this launch event, we were able to […]

Meeting Proceedings Improving HIV, HCV, STD, and Harm Reduction Services in the Era of COVID-19 and Beyond December 21, 2020 The COVID-19 pandemic has led to significant disruptions in California’s efforts to expand and improve services for HIV, hepatitis C, sexually transmitted diseases, and harm reduction. On November 18, 2020, the California HIV/AIDS Policy Research […]

Policy Brief Interventions to Combat the Infectious Disease Ramifications of the U.S. Opioid Crisis June 20, 2020 In the second of a two-part series, we explore the impact of the opioid epidemic on HIV and other health conditions in California and Nevada. Downstream consequences of the U.S. opioid epidemic, including the many lives left in […]